Jefferson Antonio Buendia

Jefferson Antonio Buendía is a paediatric pulmonologist and joined HERC in May 2023. He is currently working on economic evaluations in controlled clinical trials and estimation of the economic burden of disease. He is an associate professor at the Faculty of Medicine of the University of Antioquia, Colombia where he has worked for more than 15 years in economic evaluations of medicines and health technologies in children's health and respiratory medicine. 

He obtained his PhD in pharmacology at the University of Buenos Aires, where he worked on evaluating the impact of genetic markers on the pharmacokinetics of immunosuppressants in children with liver transplants. He obtained his MSc in clinical epidemiology at the Universidad de la Frontera in Chile, evaluating the cost-effectiveness of monoclonal antibodies in breast cancer in Colombia. He has authored more than 100 publications in high-impact journals such as The Lancet, JAMA and Pharmacoeconomics. He is currently a collaborator in the Global Burden of Disease Study with the Institute for Health Metrics at the University of Washington. 

Jefferson’s research interests lie in evaluation of the economic impact and cost-effectiveness of new drugs and effectiveness of biomarkers in personalised medicine.